Anastomotic Leak Prevention and Detection: Perfusion, Bowel Preparation, and Early Markers
Weighing what the randomized evidence actually shows for indocyanine green imaging, oral antibiotic preparation, and biochemical surveillance after colorectal resection.
One-Minute Takeaway
- Anastomotic leak after colorectal surgery is common (roughly 3–19%, higher for low rectal joins) and drives most serious postoperative morbidity; the strongest evidence here comes from network meta-analyses and multicentre randomized trials.
- Pooled data associate indocyanine green (ICG) perfusion imaging with fewer leaks (OR 0.46, 95% CI 0.36–0.59), but the largest randomized trials did not reach significance — IntAct showed 10% versus 15% clinical leak (p=0.087) and PILLAR III was flat.
- Intravenous plus oral antibiotic preparation reliably lowers surgical site infection and is linked to fewer leaks (OR 0.62); mechanical cleansing adds little on its own.
- C-reactive protein and procalcitonin are best used to rule out a leak (high negative predictive value); median time to leak diagnosis is about 6.9 days, so trends beat single values.
Why Anastomotic Leak Matters
Few complications shape colorectal outcomes as forcefully as a failed anastomosis. Reported leak rates cluster around 3–19%, rising with lower rectal joins, cancer resections, and complex reoperative fields. The consequence is not a minor setback but the dominant source of reintervention and death after these operations.
Reported mortality once a leak occurs varies widely across series, from roughly 6% to nearly 40% depending on leak severity and case mix. Beyond the immediate crisis of sepsis and reoperation, a leak lengthens hospital stay, raises cost, and has been associated with worse long-term oncological outcomes in patients operated on for cancer.
Because the stakes are so high, the field has pursued two complementary strategies: reduce the number of leaks that occur, and catch the leaks that do occur before the patient deteriorates. This review weighs three approaches that map onto both goals.
The Clinical Problem in Anastomotic Leak
An anastomotic leak is the loss of integrity at the surgical join between two bowel ends, allowing luminal contents to escape. Its origins are multifactorial, which is precisely why no single intervention has resolved it.
By convention leaks are graded by severity. Grade A requires no active intervention, grade B needs active management without reoperation, and grade C demands return to theatre. The symptomatic grades — B and C — drive the morbidity that matters most, and are the endpoint most trials try to move.
Three levers dominate the modifiable side of that risk. Tissue perfusion at the bowel ends must be adequate for healing, yet the traditional cue — the surgeon’s naked-eye read of colour and bleeding — is subjective. The colonic microbiome influences healing, and a heavy or unfavourable bacterial load may promote breakdown. And once a leak begins, its onset is insidious: clinical signs often arrive late, after the physiological damage is done.
Each lever has generated its own intervention. Perfusion assessment with indocyanine green targets the first. Oral antibiotic bowel preparation targets the second. Early biochemical markers target the third by shortening the window to diagnosis. The sections below examine what randomized evidence supports for each, and where that support runs thin.
Available Approaches
The comparative table below assembles the highest-tier evidence for each approach: large network meta-analyses and the pivotal randomized trials. It deliberately mixes prevention (ICG, bowel preparation) and detection (biochemical markers), because managing the leak problem means acting on both. Every figure was checked against its source.
| Approach | Source / design | N | Population & comparison | Key result | Tier |
|---|---|---|---|---|---|
| ICG perfusion | Tang 2022 — MA (5 RCT + 15 PSM) | 5,125 | Colorectal resection; ICG vs white-light | Leak OR 0.46 (0.36–0.59); symptomatic AL OR 0.48 (0.33–0.71) | V |
| ICG perfusion | IntAct 2025 — multicentre RCT | 766 | Rectal cancer, anterior resection; ICG vs standard | Clinical leak 10% vs 15%; adj OR 0.667 (0.419–1.060), p=0.087 | V |
| ICG perfusion | PILLAR III 2021 — multicentre RCT | 347 | Low anterior resection (≤10 cm); ICG vs standard | Leak 9.0% vs 9.6%; multivariate OR 0.85 (0.38–1.91) | V |
| Bowel prep | Tan 2023 — NMA (60 RCTs) | 16,314 | Elective colorectal; IV+oral abx±MBP vs IV alone | Leak OR 0.62 (0.41–0.94); SSI OR 0.55 (0.40–0.76) | V |
| Bowel prep | Toh 2018 — NMA (38 RCTs) | 8,458 | Elective colorectal; four preparation strategies | MBP+oral abx lowest SSI; no significant leak difference | V |
| Early markers | Bona 2023 — diagnostic MA (25 studies) | 11,144 | Colorectal; postoperative CRP and procalcitonin | CRP day-3 AUC 0.80; procalcitonin day-5 AUC 0.92 | V |
| Early markers | Singh 2014 — diagnostic MA (serum CRP) | — | Colorectal; postoperative serum CRP thresholds | Day 3–5 AUC ~0.80; high NPV, PPV 21–23% (rule-out) | V |
Perfusion Assessment with Indocyanine Green
Indocyanine green binds plasma proteins and fluoresces under near-infrared light, letting the surgeon see bowel perfusion in real time rather than infer it. Where fluorescence reveals a poorly perfused segment, the plan can change — a more proximal transection, a revised anastomosis.
Pooled analyses are encouraging. Tang and colleagues combined 20 studies and reported that ICG use was associated with roughly half the odds of leak (OR 0.46, 95% CI 0.36–0.59), with a comparable reduction for symptomatic leak (OR 0.48, 95% CI 0.33–0.71). Because most of the pooled weight is observational, this is best read as an association rather than proof.
The randomized picture is more sober. PILLAR III, a multicentre trial in low anterior resection, found nearly identical leak rates with and without ICG (9.0% versus 9.6%), though it stopped short of its target enrolment. IntAct, the largest dedicated rectal-cancer trial, observed a lower clinical leak rate with ICG (10% versus 15%) but did not cross the threshold for statistical significance (adjusted OR 0.667, p=0.087). Evidence suggests a possible benefit that the definitive trials have not confirmed.
Smaller randomized trials reinforce the pattern. A multicentre trial by De Nardi enrolled 131 patients, and others enrolled only a few hundred each, leaving them individually inconclusive. No single randomized trial has been powered to confirm a significant reduction on its own, even as the pooled and observational data continue to point the same way.
Bowel Preparation and Oral Antibiotics
Modern bowel preparation is really a question about antibiotics, not just mechanical cleansing. The strongest signal is for surgical site infection: adding oral antibiotics to intravenous prophylaxis substantially lowers infection, and society guidance now favours combined oral plus mechanical preparation.
For leak specifically, the evidence is genuinely split. The Tan network meta-analysis of 60 randomized trials found lower leak odds with intravenous plus oral antibiotics, with or without mechanical preparation (OR 0.62–0.63 versus intravenous antibiotics alone). Against this, the Toh network meta-analysis of 38 trials found the combined regimen produced the lowest infection rate but no significant difference in leak between strategies.
Two points survive that disagreement. Mechanical cleansing on its own confers little advantage once oral antibiotics are in play, and oral antibiotics without appropriate intravenous cover may even perform worse. The defensible reading is a strong, consistent benefit for infection and a plausible but inconsistent benefit for leak.
The landmark randomized trials frame the debate. MOBILE compared mechanical plus oral antibiotic preparation against no preparation for elective colectomy, and ORALEV tested oral antibiotics in a pragmatic multicentre design. Together they anchor the shift toward antibiotic-based preparation while leaving the isolated leak question unsettled.
Early Biochemical Detection
Because clinical signs lag, biochemical markers aim to flag a leak days before it declares itself. C-reactive protein is the workhorse, with procalcitonin as a complementary signal.
Their real strength is exclusion. In the Singh meta-analysis, serum CRP on postoperative days 3 to 5 carried a high negative predictive value but a positive predictive value of only 21–23% — excellent for reassurance, weak for confirmation. The Bona meta-analysis of 25 studies refined day-specific thresholds and reported strong discrimination (CRP day-3 AUC 0.80, rising to 0.84 by day 5; procalcitonin day-5 AUC 0.92), with a median time to leak diagnosis of about 6.9 days.
Preliminary evidence suggests that the trajectory of these markers outperforms any single value. A CRP that keeps climbing past its expected postoperative peak is more informative than one threshold reading, and a normal, falling marker supports safe early discharge.
Procalcitonin may add precision where CRP is equivocal. In one prospective study both markers predicted major leak, but procalcitonin was the more accurate of the two. Peritoneal and drain-fluid markers are an active area of study, though they remain less standardised than serum testing and are not yet routine practice.
Comparative Analysis
Read together, the three approaches answer different questions and carry different weights of evidence. It is a mistake to rank them on a single axis, because two aim to prevent leaks and one aims to detect them.
On leak prevention, bowel preparation with combined antibiotics rests on the largest randomized base, though its leak benefit is inconsistent across network analyses and its infection benefit is far more secure. ICG has a strong observational and pooled signal, but the two largest randomized trials did not confirm a significant reduction in clinical leak — a gap between promise and proof that defines the current debate.
On detection, biochemical markers occupy a distinct role. They do not prevent anything; they compress the interval between a silent leak and its recognition, and they are most trustworthy as a rule-out test that supports discharge decisions. In practice these approaches are layered, not chosen: antibiotic preparation before the operation, perfusion assessment during it, and marker surveillance after it.
Cost and workflow also separate them. Biochemical markers are inexpensive and already routine, antibiotic preparation is low-cost and widely available, and perfusion imaging requires specific equipment and a short learning curve. Evidence strength and practicality therefore align for the first two and demand more judgement for the third.
The honest synthesis is that no approach abolishes anastomotic leak. Each shifts the odds or the timeline modestly, and their evidence bases differ enough that combining them is more defensible than relying on any one.
Quality and Consistency of the Evidence
Strength of evidence varies markedly by claim, and matching language to that strength matters here more than usual.
- High — oral antibiotics for infection. Multiple large randomized trials and consistent network meta-analyses support reduced surgical site infection with combined intravenous and oral antibiotic preparation.
- Moderate — marker discrimination. Diagnostic meta-analyses converge on strong negative predictive value for CRP and procalcitonin, though thresholds and heterogeneity vary between studies and surgical approaches.
- Moderate but contested — ICG for leak. Pooled and observational data suggest benefit, yet the two largest randomized trials did not reach significance; heterogeneity in imaging systems and dosing persists.
- Low — bowel preparation for leak. Network analyses disagree on whether antibiotic preparation reduces leak specifically, and mechanical cleansing alone shows no clear advantage.
What the Evidence Does Not Show
- Whether ICG reduces clinical leak in adequately powered trials — PILLAR III was underpowered and IntAct did not reach significance, so a modest true effect cannot be excluded or confirmed.
- How much of any ICG benefit is the dye versus the changed intraoperative decision it prompts, which trial designs struggle to isolate.
- Whether the leak signal attributed to oral antibiotics is independent of their infection benefit, given conflicting network meta-analyses.
- The optimal marker strategy — single threshold versus daily trajectory, and validated cut-offs specific to laparoscopic versus open surgery.
- Whether combining perfusion imaging, antibiotic preparation, and marker surveillance produces additive benefit; no trial has tested the bundle head-to-head.
None of these gaps is closed by the current literature, and each is a genuine target for future randomized work rather than a matter of interpretation.
Practical Implications
The evidence supports a layered posture rather than a single decisive intervention. Combined intravenous and oral antibiotic preparation is the best-supported preoperative step, chiefly for infection and plausibly for leak, while routine mechanical cleansing adds little by itself.
Intraoperative perfusion assessment with ICG is safe and can objectively confirm bowel viability; the evidence supports its use as a decision aid, while acknowledging that a guaranteed leak reduction has not been demonstrated in the largest trials. Postoperatively, CRP and procalcitonin are most useful as reassurance: a low, falling marker supports early discharge, whereas a rising trajectory warrants closer scrutiny before signs appear.
These statements describe what the evidence supports, not a mandate. Local protocols, case mix, and resource availability reasonably shape how each approach is applied.
Evidence Grade and Bottom Line
- Combined oral and intravenous antibiotic preparation has strong evidence for reducing infection and a plausible signal for reducing leak.
- ICG perfusion imaging is supported by pooled data but not confirmed by the largest randomized trials for clinical leak reduction.
- CRP and procalcitonin are well-validated rule-out tests for early leak, strongest when read as trends rather than single values.
- No approach eliminates anastomotic leak; the defensible strategy layers prevention before and during surgery with biochemical surveillance afterward.
The bottom line is measured optimism. Each approach moves the needle modestly and on different terms, and the most honest recommendation is to combine well-supported steps while watching the definitive perfusion-imaging trials that are still maturing.
Article Information and References
- Tang G, Du D, Tao J, Wei Z. Effect of indocyanine green fluorescence angiography on anastomotic leakage in patients undergoing colorectal surgery: a meta-analysis of randomized controlled trials and propensity-score-matched studies. Front Surg. 2022;9:815753. DOI: https://doi.org/10.3389/fsurg.2022.815753
- Tan J, Ryan ÉJ, Davey MG, et al. Mechanical bowel preparation and antibiotics in elective colorectal surgery: network meta-analysis. BJS Open. 2023;7(3):zrad040. DOI: https://doi.org/10.1093/bjsopen/zrad040
- Toh JWT, Phan K, Hitos K, et al. Association of mechanical bowel preparation and oral antibiotics before elective colorectal surgery with surgical site infection: a network meta-analysis. JAMA Netw Open. 2018;1(6):e183226. DOI: https://doi.org/10.1001/jamanetworkopen.2018.3226
- Rollins KE, Javanmard-Emamghissi H, Acheson AG, Lobo DN. The role of oral antibiotic preparation in elective colorectal surgery: a meta-analysis. Ann Surg. 2019;270(1):43–58. DOI: https://doi.org/10.1097/SLA.0000000000003145
- Bona D, Danelli P, Sozzi A, et al. C-reactive protein and procalcitonin levels to predict anastomotic leak after colorectal surgery: systematic review and meta-analysis. J Gastrointest Surg. 2023;27(1):166–179. DOI: https://doi.org/10.1007/s11605-022-05473-z
- Singh PP, Zeng ISL, Srinivasa S, Lemanu DP, Connolly AB, Hill AG. Systematic review and meta-analysis of use of serum C-reactive protein levels to predict anastomotic leak after colorectal surgery. Br J Surg. 2014;101(4):339–346. DOI: https://doi.org/10.1002/bjs.9354
- Yeung DE, Peterknecht E, Hajibandeh S, Hajibandeh S, Torrance AW. C-reactive protein can predict anastomotic leak in colorectal surgery: a systematic review and meta-analysis. Int J Colorectal Dis. 2021;36(6):1147–1162. DOI: https://doi.org/10.1007/s00384-021-03854-5
- Jayne D, Croft J, Corrigan N, et al. Intraoperative fluorescence angiography with indocyanine green to prevent anastomotic leak in rectal cancer surgery (IntAct): an unblinded randomised controlled trial. Lancet Gastroenterol Hepatol. 2025;10(9):806–817. DOI: https://doi.org/10.1016/S2468-1253(25)00101-3
- Jafari MD, Pigazzi A, McLemore EC, et al. Perfusion assessment in left-sided/low anterior resection (PILLAR III): a randomized, controlled, parallel, multicenter study. Dis Colon Rectum. 2021;64(8):995–1002. DOI: https://doi.org/10.1097/DCR.0000000000002007
- Alekseev M, Rybakov E, Shelygin Y, Chernyshov S, Zarodnyuk I. A study investigating the perfusion of colorectal anastomoses using fluorescence angiography: results of the FLAG randomized trial. Colorectal Dis. 2020;22(9):1147–1153. DOI: https://doi.org/10.1111/codi.15037
- Koskenvuo L, Lehtonen T, Koskensalo S, et al. Mechanical and oral antibiotic bowel preparation versus no bowel preparation for elective colectomy (MOBILE): a multicentre, randomised, parallel, single-blinded trial. Lancet. 2019;394(10201):840–848. DOI: https://doi.org/10.1016/S0140-6736(19)31269-3
- Espín-Basany E, Solís-Peña A, Pellino G, et al. Preoperative oral antibiotics and surgical-site infections in colon surgery (ORALEV): a multicentre, single-blind, pragmatic, randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5(8):729–738. DOI: https://doi.org/10.1016/S2468-1253(20)30075-3
- Migaly J, Bafford A, Francone T, et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the use of bowel preparation in elective colon and rectal surgery. Dis Colon Rectum. 2019;62(1):3–8. DOI: https://doi.org/10.1097/DCR.0000000000001238
- Garcia-Granero A, Frasson M, Flor-Lorente B, et al. Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study. Dis Colon Rectum. 2013;56(4):475–483. DOI: https://doi.org/10.1097/DCR.0b013e31826ce825
- De Nardi P, Elmore U, Maggi G, et al. Intraoperative angiography with indocyanine green to assess anastomosis perfusion in patients undergoing laparoscopic colorectal resection: results of a multicenter randomized controlled trial. Surg Endosc. 2020;34(1):53–60. DOI: https://doi.org/10.1007/s00464-019-06730-0